Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07711548
NA

Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?

Sponsor: Knut Mai

View on ClinicalTrials.gov

Summary

So far, treatment with semaglutide (Wegovy) for therapy of obesity demonstrates substantial effects. However, most patients do not desire life-long pharmaceutical therapy or discontinue this treatment regime. This is accompanied by rapid weight regain. Moreover, numerous patients are open to an intermittent therapy. This trial aims to investigate whether two diet interventions can keep weight stable after weight loss with semaglutide in people with obesity or overweight.

Official title: DIETary Strategies to stabiLize Incretin-based Weight Loss in Obesity Management

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

292

Start Date

2027-03

Completion Date

2030-04

Last Updated

2026-07-20

Healthy Volunteers

No

Interventions

BEHAVIORAL

NutriAct plus

Dietary pattern, vegetarian version of the NutriAct pattern

BEHAVIORAL

Rescue VLCD

Very low calorie diet as full meal replacement over 28 days in case of weight regain